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The interactions between humans and the
ocean are significant and necessitate more
comprehensive study on an international
scale. The world’s oceans provide great health
benefits to humans, ranging from food and
nutritional resources, to recreational opportu-
nities, to new treatments for disease. The
rising human population and trends in migra-
tion to the world’s coastal zones continue to
increase pressure on this ocean/land interface.
Coastal degradation, climate variability, and
increased industrialization may pose human
health risks from mobilization and transport
of anthropogenically derived and natural
toxic agents in the environment (Harvell et
al. 1999). A National Research Council
report on the interactions between ocean and
public health, From Monsoons to Microbes:
Understanding the Ocean’s Role in Human
Health, has recently been published (National
Research Council 1999). International efforts
to focus on ocean health and human health
issues have been made by the Health of the
Ocean panel of the Global Ocean Observing
System (UNESCO 1996) as well as a meeting
held in Bermuda, 15–19 November 1999
(Knap 2000). These programs have built on
the National Research Council report but
have focused specifically on indicators of the
effects of anthropogenic agents as well as nat-
ural toxins, and on questions targeting the
development of biologic markers linking
exposure with human and ecologic health
end points.
For our purposes, the term “ocean” is all
encompassing, ranging from brackish to open
ocean conditions. We have defined ocean
health in the broadest sense as adopted from
the Health of the Ocean panel of UNESCO
(1996) as a “reflection of the condition of the
marine environment from the perspective of
adverse effects caused by anthropogenic activ-
ities, in particular habitat destruction,
changed sedimentation rates and the mobi-
lization of contaminants” (p. 3). Such condi-
tions refer to the contemporary state of the
ocean, prevailing trends, and the prognosis
for improvement or deterioration in its qual-
ity. Most contamination is concentrated in
the coastal zone from a variety of sources;
however, long-range transport can deliver
contaminants great distances (Knap 1990)
and can affect the health of remote human
populations (Dewailly et al. 2000). Finally,
human health is defined as “a state of com-
plete physical, social and mental well being,
and not merely the absence of disease or infir-
mity; health is a resource for everyday life,
not the object of living. It is a positive con-
cept emphasizing social and personal
resources as well as physical capabilities”
(World Health Organization 1946: p. 100).
Background
Presently, 60% of the world’s population is
estimated to live in coastal areas (GESAMP
2001). In fact, the present population of
coastal areas exceeds the global population of
just 50 years ago (Bowen and Crumbley
1999). This settlement pattern has exacer-
bated the rate of change in coastal systems and
has already placed the goal of “sustainable
development”—the balanced socioeconomic
benefit of the marine environment—out of
reach for some regions. The world population
is estimated to increase from about 6 billion
currently to 8.3 billion by 2025, with 90% of
this growth occurring in subtropical and
tropical countries. Over two billion people
worldwide rely on seafood as a major source
of protein in their diet, and seafood con-
sumption continues to increase worldwide
(FAO 1999). Additionally, the sustainability
of remote coastal populations depends on a
source of uncontaminated seafood. Natural
stocks of seafood have been supplemented by
the aquaculture industry. However, marine
aquaculture may cause habitat destruction
and pollution of the local environment
through the production of waste products
(National Research Council 1999).
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We need to critically assess the present quality of the marine ecosystem, especially the connection
between ecosystem change and threats to human health. In this article we review the current state
of indicators to link changes in marine organisms with eventual effects to human health, identify
research opportunities in the use of indicators of ocean and human health, and discuss how to
establish collaborations between national and international governmental and private sector
groups. We present a synthesis of the present state of understanding of the connection between
ocean health and human health, a discussion of areas where resources are required, and a discus-
sion of critical research needs and a template for future work in this field. To understand fully the
interactions between ocean health and human health, programs should be organized around a
“models-based” approach focusing on critical themes and attributes of marine environmental and
public health risks. Given the extent and complex nature of ocean and human health issues, a pro-
gram networking across geographic and disciplinary boundaries is essential. The overall goal of
this approach would be the early detection of potential marine-based contaminants, the protection
of marine ecosystems, the prevention of associated human illness, and by implication, the develop-
ment of products to enhance human well-being. The tight connection between research and mon-
itoring is essential to develop such an indicator-based effort. Key words: biologic effects,
biomarkers, contamination, human health, indicators, ocean health. Environ Health Perspect
110:839–845 (2002). [Online 17 July 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p839-845knap/abstract.html
Commentary
Many types of contaminants threaten the
marine system. Figure 1, adapted from the
Global Ocean Observing System’s Health of
the Ocean Report (UNESCO 2002), pro-
vides an overview of the general types of vari-
ables measured under various international
programs and relates these to measures of
ecosystem integrity. It also shows the relation-
ship between sustainable development and
human health. Only a subset of these are of
specific concern to the issue of ocean and
human health. These include synthetic
organic chemicals, specific heavy metals, algal
toxins, pathogens, pharmaceuticals, and pos-
sibly genetically modified organisms. Many of
the other contaminants in Figure 1 do not
have a specific pathway from the ocean to
people, or if they do, the consensus of the
recent conference in Bermuda (Knap 2000)
was that evidence was insufficient to warrant
their special consideration here.
Recently, human health effects from expo-
sure to the marine food chain have been high-
lighted by a number of studies (Grandjean et
al. 1997; Marsh et al. 1995; Mulvad et al.
1996). Routes of exposure include eating, skin
contact, and breathing. A major concern for
public health is the ingestion of contaminated
seafood, putting those humans who eat conta-
minated seafood over time at the greatest risk.
Synthetic organic chemicals. Synthetic
organic chemicals are a loosely defined group
of substances that, aside from petroleum
hydrocarbons and polycyclic aromatic hydro-
carbons (PAHs), include all synthetic sub-
stances that result from industrial activities.
Their introduction to the marine environment
arises from direct discharge (point sources),
discharge to municipal sewage systems or
rivers, and venting to the atmosphere. These
compounds are best classified in terms of their
source functions (size and nature of the land-
based sources), persistence, bioavailability, ten-
dency to bioaccumulate, and toxicity.
Substances of particular concern are
chlorobiphenyls, chlorinated dioxins, and
some industrial solvents. Current scientific
knowledge of these compounds is extensive
but still not complete, and new compounds
continue to be identified in animal tissue. For
example, the flame retardants polybromi-
nated biphenyls and polybrominated
diphenyl ethers have been reported recently
in sperm whales, which feed in deep waters.
Along with tetrabromobisphenol-A and hexa-
bromocyclododecane, global production of
these compounds is approximately 150,000
tons per year (DeBoer et al. 1998).
Some pesticides and herbicides also pose
potential hazards to human health. Some syn-
thetic organic chemicals have been linked to
possible endocrine-disrupting functions.
Herbicide and pesticide exposure seen in
wildlife, including marine and freshwater
organisms, may be linked with reproductive
and developmental problems seen in humans
(Heindel et al. 1998).
Human exposure to synthetic organics
occurs primarily from eating contaminated
foods. A large number of studies (e.g., AMAP
1998) related to this issue have been per-
formed in remote fishing communities in the
Arctic, because these lipophilic contaminants
are transported by the atmosphere, deposited
in the land and water, ingested by wildlife,
and biomagnified up the marine food web,
ultimately being consumed by humans living
in these regions. Unfortunately, because the
“environmental soup” has many different
contaminants, relating a deleterious effect in
specific marine organisms to the action of a
specific compound is very difficult. However,
studies suggest that polychlorinated biphenyls
(PCBs) have a variety of effects on human
reproduction, neurobehavioral development,
liver function, birth weight, immune response,
and tumorigenesis (Dewailly et al. 2000;
Heindel et al. 1998). Studies in Arctic popu-
lations have linked fetal cord blood PCB con-
centrations with low birth weight, small head
circumference, and immunosuppression
(AMAP 1998).
Other organic contaminants are also of
concern. For example, human exposure to
dioxins is a concern for public health.
Dichlorodiphenyltrichloroethane (DDT) was
banned in the United States and Europe in
1972 but is still being used in tropical and
subtropical countries for malaria control. The
International Agency for Research on Cancer
(IARC) considers DDT to be “possibly” car-
cinogenic. DDT is regarded as an estrogen
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Figure 1. Relationship between global ocean health and sustainable development. Adapted from UNESCO
2002.
mimic, and dichlorodiphenyldichloroethylene
(DDE) is an androgen receptor antagonist.
Subacute levels of exposure show effects on
the central nervous system of humans.
Studies continue on the effects of neonatal
synthetic organic exposure in the Arctic
(AMAP 1998).
Although we have much information on
the transfer of organochlorine residues
through the marine food web, our knowledge
on the transfer to humans through this path-
way has been limited to a few classes of conta-
minants. However, evidence suggests that the
organochlorine pesticide dieldrin (the epoxide
of aldrin) affects the central nervous system
and liver in humans. Generally, how to dis-
cern specific compounds and their effects in a
large pool of contaminants present in the
ocean environment is unclear.
PAHs. PAHs are derived from thermal
transformations of fossil fuel, primarily petro-
leum. Some PAHs are formed by naturally
occurring, low-temperature metamorphic
processes. They enter the marine system
through municipal or industrial effluents, via
atmospheric pathways from industrial emis-
sions, or through exhaust fumes of internal
combustion engines and domestic heating sys-
tems. The known carcinogenic effects of some
PAHs are of primary concern for human
health. PAHs enter humans primarily through
food consumption. For example, among non-
smokers, 99% of total benzo[a]pyrene levels
come from ingestion (Kennish 1997). PAHs
bioaccumulate in marine organisms such as
bivalves and are regarded as animal carcino-
gens. They can be absorbed by the human
body, metabolized by the liver and kidney,
and eliminated via feces and urine. The health
outcomes associated with PAH exposure
include lung cancer, low birth rates, and
decreased fecundity (AMAP 1998).
Metals. The metals group is composed of
all metals and metalloids in the marine environ-
ment. It is important to distinguish between
the introduction of metals from anthropogenic
activities and those from natural weathering
processes. Although sources of metals in the
marine environment are numerous and diverse
(elevated metal levels accompany almost every
type of effluent), little evidence of widespread
adverse biologic effects exists other than risks to
human health posed by metals in seafood
species (Brouwer et al. 1998). Elevated metal
levels in seawater are unlikely (other than in the
immediate vicinity of point sources), due in
most cases to their rapid removal by adsorption
to suspended particulate materials. Tributyl-tin
(used as a constituent in anti-fouling paints on
boats) and methyl mercury (formed by the
microbial methylation of mercury) are two
highly toxic compounds that have been respon-
sible for well-recorded marine pollution inci-
dents. The basis of bioaccumulation and
toxicity for these substances lies in their forms
of speciation. Thus, special attention may be
required to identify specific forms of other
metals in the future.
Mercury is used in a wide range of indus-
trial processes and mining practices. Once it is
released into anoxic environments, bacteria can
rapidly methylate this metal. Methyl mercury
is highly lipophilic and is biomagnified in the
environment (Dewailly et al. 2001). Its half-
life is 60–120 days in humans and up to 2
years in fish. Methyl mercury causes cytotoxic,
kidney, and brain damage, with concentrations
of 1–2 mg/kg in brain tissue producing neuro-
toxic effects. Fetal exposure to methyl mercury
is of great concern. As expected, individuals
who consume seafood have the highest con-
centrations of methyl mercury in their tissues.
Average hair concentrations of humans eating
10–20 g/day are less than 1 ppm. However,
among individuals poisoned by methyl mer-
cury in Japan and Iraq, concentrations of
50–100 ppm were found in hair samples
(Harada 1995). Environmentally chronic
exposures have been reported in populations
dependent on fishing in Amazonia, Coastal
Peru, Seychelles, Faroe Islands, the Arctic, and
New Zealand (Davidson et al. 1998;
Grandjean et al. 1997; Kjellstrom et al. 1986;
Marsh et al. 1995; McKeown-Eyssen et al.
1983; Myers et al. 1995).
Cadmium can bioaccumulate in the envi-
ronment, including the ocean environment,
and its uptake by humans is affected by the
uptake of lead. The IARC has labeled cad-
mium as a Group I carcinogen (known
human carcinogen). The major health risk
associated with cadmium is nephrotoxicity
(proteinuria and renal failure).
Environmental exposures to lead have
been linked to poor neural development in
children, but no cases of lead poisoning
related to a marine source have been docu-
mented. Some studies (e.g., Hansen et al.
1991) on human lead blood levels in
Greenland have indicated concentrations sim-
ilar to those of people in Western Europe.
Whether this is a direct effect of atmospheric
transport or from seafood ingestion is not yet
clear (Dewailly et al. 1999). The use of
leaded gasoline in the developed world has
decreased but remains an issue in less devel-
oped areas of the world. Arsenic is also a
highly toxic metal, but, as with lead, no
known arsenic poisonings have occurred as a
result of marine exposures or consumption of
seafood. Both arsenic and lead occur in
marine sediments as a result of industrial dis-
charge. Like mercury, arsenic can be con-
verted to more lipophilic and toxic methyl
forms. Although the effects of these metals
on marine ecologic health are known, the
specific mechanisms of transfer to humans
needs more attention.
Marine toxins. Although many definitions
of marine toxins exist, the Health of the Ocean
panel for the Global Ocean Observing System
has defined algal toxins as compounds that are
produced by marine organisms on a scale large
enough to induce adverse effects on communi-
ties of higher marine organisms (National
Research Council 1999). In turn, humans may
be exposed through the consumption of
seafood or through dermal contact from occu-
pational or recreational exposure to a toxin. In
the case of Gymnodinium breve (Florida red
tide), blue-green algae (cyanobacteria), and
possibly Pfiesteria piscicida, transfer of toxins to
humans may also occur through inhalation of
aerosols containing the toxin.
Algal toxin outbreaks are mainly associ-
ated with dinoflagellates, of which approxi-
mately 60 species cause red tides and about
30 produce biotoxins. Of the 5,000 known
species of phytoplankton, approximately 80
are toxic (Hackney and Pierson 1994). An
increase in documented illness from exposure
to marine biotoxins may be due to an increas-
ingly stressed marine environment, an
increase in reporting because of greater vigi-
lance, increased seafood distribution world-
wide, and a larger range of worldwide tourist
travel (Hallegraef 1993). Accurately assessing
overall health risks from exposure to marine
toxins is virtually impossible, because few
data exist on their transfer through the coastal
food web, primarily because many of the
milder cases go unreported and thus are not
recorded in databases. Different toxins have
different effects. Occupational exposure to
the dinoflagellate Pfiesteria has reportedly
been linked to nausea, respiratory problems,
and severe memory loss (Grattan et al. 1998).
However, Pfiesteria is difficult to assess
because samples of this single organism are
hard to collect, its toxins have yet to be char-
acterized, and the inhalation exposure is diffi-
cult to measure (Fleming et al. 1999).
Currently, 20 types of paralytic shellfish
poisons (PSPs) have been identified, of
which saxitoxin is the major toxin (Table 1),
a sodium channel blocker, with primary
symptoms of paresthesias and paralysis. The
neurotoxic shellfish poison (NSP) toxin
brevetoxin acts in the opposite manner,
opening sodium channels rather than block-
ing them. Brevetoxins have less neurotoxic
effect than do PSP toxins, but they are easily
aerosolized and when inhaled can lead to res-
piratory infection, coughing, and bron-
chiospasms. Exposure to the amnesic shellfish
poison (ASP) toxin domoic acid can lead to
seizures, coma, amnesia, and formation of
lesions in the brain. The diarrheic shellfish
poison (DSP) toxin okadaic acid leads to self-
limiting gastrointestinal symptoms, and cases
of poisonings from this toxin are probably
dramatically underreported (Baden et al.
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1995). The ciguatera fish poison (CFP) toxin
ciguatoxin has been documented in up to 400
species of fish, remaining in fish for over 2
years, and is responsible for more than half of
all reported seafood-related illnesses (~50,000
reported cases/year). 
Like other types of seafood poisoning,
many cases of ciguatoxin poisoning likely go
unreported. Symptoms from exposure vary
geographically. In Polynesia CFP symptoms
are usually neurologic, whereas in the
Caribbean the initial symptoms include gas-
troenteritis and cardiovascular problems.
Microbial risks. Pathogens in the marine
environment are a significant human health
concern. Exposure can occur by eating conta-
minated seafood and through occupational
and recreational exposures (HEED 1998).
The primary sources of human pathogens are
untreated human and animal wastes,
although transmission can occur between
swimmers or, potentially, from seabirds or
other wildlife. One of the major causes of
reported seafood illnesses is the consumption
of raw shellfish contaminated by sewage. A
large amount of quantitative epidemiologic
and toxicologic information exists on human
risks of infectious disease from contaminated
seafood consumption and other routes of
exposure from seawater. Routes of human
exposure include eating contaminated
seafood, direct ingestion of seawater, and der-
mal exposure to both water and sediments
(Clark et al. 1997). A recent study has esti-
mated that wastewater-related sickness causes
economic losses of approximately $8.8 billion
per year (GESAMP 2001).
Among the microbial agents related to
seafood-borne illnesses, viruses are the most
common form of infection, followed by bac-
teria and then protozoa. The major vectors of
viral infection are marine bivalves such as oys-
ters and clams, and the effects are numerous
and vary by virus. For example, the Norwalk
virus is responsible for 23% of reported
waterborne gastroenteritis outbreaks (General
Accounting Office 1984). Among the bacte-
ria, Vibrio vulnificus has been implicated in a
number of shellfish poisonings and wound
infections. Other Vibrio spp. such as toxi-
genic Escherichia coli, Shigella spp., and
Salmonella spp. can also be contracted from
ingesting contaminated foods and water.
Information on survival of these pathogens in
seawater is limited.
Very little information exists for the proto-
zoa and their potential impact on ocean and
human health. Cryptosporidium spp. accumu-
lates in shellfish, but to date no outbreaks
related to this protozoan associated with
seafood consumption have been reported.
Gastrointestinal illnesses have been epidemio-
logically linked to scuba diving in sewage-cont-
aminated waters (MMWR 1983). Anasikiasis
is a rare nematode (roundworm) infection
acquired through consumption of raw fish and
cephalopods (Deardoff and Overstreet 1991);
a similar disease associated with the helminthes
Gnathostoma has been reported in Southeast
Asia and the Middle East (Anantaphruti
2001). Diphyllobothriasis, or fish tapeworm
disease, was traditionally associated with
gefilte fish preparation by Jewish women;
approximately 10% of people in Scandinavia
are reportedly infected with Diphyllobothrium
(Fleming et al. 2000).
In general, infections appear to have
increased among individuals recreationally
and occupationally exposed to seawater
(Henrickson et al. 2001), including gastroin-
testinal, dermal, respiratory, eye, ear, nose
and throat infections. Furthermore, children
are at greater risk to greater exposures and are
uniquely susceptible because of their physiol-
ogy and development (Landrigan et al. 1998).
Also, a child’s potential long-term health
problems from a variety of exposures could
have significant economic consequences.
Environmental and Human
Health Indicators
The marine environment. The key objectives
in any assessment of marine environmental
health on a regional or global scale are to pro-
vide information necessary to ensure the
maintenance of biodiversity and the integrity
of marine communities, minimize the loss of
species, limit human influences on living
resources (including genetic richness), protect
critical habitats, and safeguard human health.
All of these objectives are vital to ensuring
sustainable development of coastal and
marine resources.
Changes in community structure and
measures of chemical contamination have
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Table 1. Human intoxication syndromes caused by marine toxins.
Disease PSP NSP ASP DSP Ciguatera Puffer fish
Causative organism Red tide Red tide Red tide diatom Red tide Epibenthic Bacteria?
dinoflagellate dinoflagellatea dinoflagellate dinoflagellate
Major transvector Shellfish Shellfish, aerosols Shellfish Shellfish Fish Fish
Geographic distribution Temperate to Gulf of Mexico, Canada, NW United States Temperate worldwide Subtropical to Japan, worldwide
tropical worldwide Japan, New Zealand tropical worldwide
Major toxin (no.) Saxitoxin (≥ 18)b Brevetoxin (≥ 10)b Domoic acid (3)b Okadaic acid (4)b Ciguatoxin (≥ 8)b Tetrodotoxin (≥ 3)b
scaritoxin, maitotoxin
Neuromechanism Na+ channel Na+ channel Glutamate Phosphorylase Na+, Ca2+ Na+
blocker activator receptor agonist phosphatase inhibitor channel activators channel blocker
Incubation time 5–30 min 30 min to 3 hr Hours Hours Hours 5–30 min
Duration Days Days Years Days Years Days
Acute symptoms n,v,d,p,r n,v,d,b*,t*,p n,v,d,a*,p,r d*,n,v n,v,d,t*,p n,v,d,p*,r*,↓bp*
Chronic symptoms None None Amnesia None Paresthesias None
Fatality rate (%) 1–14 0 3 0 < 1 (0.1–12) 60
Chronic effects None observed Hypersensitivity, Memory loss Tumor Recurrent None observed
immune depression promotion symptoms
Diagnosis Clinical, Clinical, Clinical, Clinical, Clinical, Clinical,
mouse bioassay mouse bioassay mouse bioassay mouse bioassay, mouse bioassay, mouse bioassay,
of food, HPLC of food, ELISA of food, HPLC HPLC, ELISA immunoassay fluorescence
Therapy Supportive Supportive Supportive Supportive Mannitol, Supportive
(respiratory) (respiratory) TCA?, (respiratory)
supportive
Prevention Red tide Red tide, Seafood Seafood Seafood Regulated
and seafood then seafood surveillance, surveillance, surveillance, food preparation,
surveillance, surveillance, report cases some red tide, report cases report cases
report cases report cases report cases (clusters)
Abbreviations: a, amnesia; b, bronchoconstriction; ↓bp, decreased blood pressure; d, diarrhea; ELISA, enzyme-linked immunosorbent assay; HPLC, high-performance liquid chromatog-
raphy; n, nausea; NW, northwest; p, paresthesias; r, respiratory depression; t, reversal of temperature sensation; TCA, tricyclic antidepressant; v, vomiting. 
aChattonella raphidophyte from Delaware implicated in 2000. bNumbers in parentheses indicate number of natural derivatives. Data from Baden et al. (1995), with updates from
Bourdelais et al. (2002). *Pathognomonic symptoms.
generally been used to indicate the state of
ecosystem health. However, such high-level
responses are generally too complex and far
removed from causative events because they
are manifestations of damage rather than pre-
dictive indices. Detection of lower-level
changes (molecular, cellular, physiologic, and
behavioral responses) that underlie higher-
level effects and for which causality can be
established may provide the desired early
warning of impending environmental dam-
age. Individual and subindividual responses
may also be amenable to detection by auto-
mated monitoring systems. Four approaches
to gathering information on indicators are
biomarkers, cellular pathology, physiologic
and behavioral responses, and changes in
populations. All hold the potential to
enhance our understanding of marine envi-
ronmental quality and far-reaching effects on
human health.
Our knowledge of distress signals has
grown substantially in the past decade, often
drawing on our reservoir of knowledge of
humans and rodents. The use of biomarkers
(indicators) in marine environmental toxicol-
ogy is increasing, and their potential power is
significant. They may be not only diagnostic
predictors of pathologic change but also bio-
markers of exposure for specific classes of
toxic chemicals (xenobiotics) and certain trace
metals. This latter type of biomarker has the
potential to provide rapid and less costly
alternatives to routine chemical analytical
screening. Chemical analytical efforts could
then be focused on more specific fingerprint-
ing work, thereby helping to elucidate the
link between cause and effect.
Potential marine biomarkers (indicators)
include alterations in intracellular membranes
(e.g., endoplasmic reticulum, lysosomes, endo-
somes, transport vesicles), genotoxicity (e.g.,
oxidative adducts, micronuclei), specific pro-
teins or enzymes (e.g., metal-binding proteins,
stress proteins, oncoproteins, cytochrome
P-450, multidrug-resistant proteins), and inhi-
bition of cholinesterase by neurotoxins (e.g.,
organophosphates, carbamates). Some of these
biomarkers, such as membrane changes and
stress proteins, indicate cell injury and poten-
tial damage to health, whereas others, such as
DNA adducts, cytochrome P-450 (e.g.,
CYP1A and ethoxyreorufin o-deethylase), mul-
tidrug-resistant protein, and metal-binding
proteins, indicate exposure to certain classes of
xenobiotics and metals (Intergovernmental
Oceanographic Commission 2001).
The use of molecular and cellular bio-
markers coupled with cellular pathology
(histopathology) provides further clues to the
source of the specific environmental problem.
Histopathologic change can be easily and
accurately quantified using microstereologic
procedures applied to tissue sections. These
data can then be correlated with both cell
injury processes and abnormalities in physiol-
ogy. Linking these measurements with physi-
ologic and behavioral responses, and more
traditional population and community moni-
toring, will provide a set of early and long-
term warning systems for the environment.
Recent developments have led to new
methods, which have been tested in the field
(Wedderburn et al. 2000). Studies have inves-
tigated a neutral red retention assay (Lowe et
al. 1995) with histopathalogic measurements,
as well as determining the physiologic state of
mussels using a heart beat monitor in the field
(Aagaard et al. 1995). The neutral red reten-
tion assay involves sampling the fluid from
mussels, staining the fluid, and timing how
long the cells retain the stain. Healthy animals
retain stain for hours, and those less healthy
can lose the stain in minutes. The use of these
nondestructive techniques should be encour-
aged and are already part of a field monitoring
assessment program for coastal Brazil.
A recent article comparing U.S.
Environmental Protection Agency
Environmental Monitoring and Assessment
Program Estuaries Program data with
National Oceanic and Atmospheric Agency
bioeffects data on sediment chemistry and
toxicity identified no apparent chemical mea-
surement that successfully predicted toxicity
(O’Connor and Paul 2000). This result chal-
lenges many theories on the use of sediments
as monitors of contamination and deserves
further investigation. Metabolites and break-
down products of contaminants may be the
primary sources of toxicity long after the
concentration of the parent compound is no
longer detected (Ehrhardt and Knap 1989).
Despite these challenges, indicators continue
to play an important role in our understand-
ing of marine environmental health. Efforts
are underway to develop microbial biomark-
ers of contaminant exposure because
microorganisms adapt rapidly to changing
environments and can be probed for expres-
sion of genes that convey resistance to toxic
chemicals or catabolic potential for organic
pollutants (Ford 2000).
Human health. It is clear that challenges
remain to developing a better understanding
of the connection between the marine envi-
ronment and human health. Environmental
changes do affect human health, and it is
important to identify which indicators have
enough sensitivity and specificity to detect
these changes. Human mortality and morbid-
ity registries alone are not likely to help moni-
tor environmental changes, because most
chronic human diseases are multifactorial and
involve genetic, lifestyle, and environmental
factors. It is therefore also unlikely that cancer
registries or mortality rates will provide a
useful indication of changes for ocean-related
illnesses because of issues regarding specificity
and the long delay (10–20 years) between
exposure to environmental risk factors and
detection of cancer. However, morbidity reg-
istries on acute diseases such as marine toxin
poisoning and other seafood-borne diseases,
reporting of which is mandatory in most
countries, could provide useful information
on any changes in incidence over time.
Because these diseases are largely underre-
ported, we urgently need to improve and vali-
date these surveillance systems. Health
registries are also very useful for monitoring
shorter latency events such as pregnancy com-
plications (low birth weight, congenital mal-
formations, and the like).
Specific clinical effects related to contami-
nants have been the subject of numerous epi-
demiologic studies. In general populations
exposed to low doses, only subtle effects are
expected to occur. For lead and cadmium,
epidemiologic studies and animal experi-
ments provide sufficient data to set thresholds
for human exposure. The general consensus is
that 10 µg/dL is the maximum blood lead
concentration accepted for children. In this
case, measuring blood lead in a group of chil-
dren is a relatively easy, cheap, valid, and
manageable biomarker to assess both expo-
sure and risk in children. However, for most
ocean-related contaminants such as methyl
mercury and persistent organic pollutants,
results from epidemiologic studies are more
contradictory. Cohort studies in Michigan
(Jacobson and Jacobson 1996) and North
Carolina (Rogan et al. 1986) have provided
conflicting results on neurobehavioral
changes in children who were exposed prena-
tally to PCBs. Conflicting results were also
reported on neurologic impairments in chil-
dren who were exposed to methyl mercury
during fetal development; a study in the
Seychelles did not report any deleterious
effects (Davidson et al. 1998), whereas a
cohort study in the Faroe Islands found sig-
nificant neurotoxic effects (Grandjean et al.
1997). There may be many reasons for these
discrepancies, including differences in meth-
ods, exposure mixtures, nutritional interac-
tions, and genetic susceptibility.
Unfortunately, cohort studies are
extremely expensive in both time and
resources and require large multidisciplinary
scientific groups. In addition, new xenobi-
otics or metabolites are regularly identified by
analytical chemists, and health officials may
not be able to react in a timely manner. To
complement standard disease registries and
epidemiologic cohort studies, scientists have
tried to develop early response biomarkers to
detect any reversible or irreversible biologic
effects. Potential early warning signal markers
deal with the immune system (cytokines, cell
markers, antibody response to immunization,
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and the like), endocrine activity (hormones
such as sexual or thyroid), genotoxicity (DNA
and protein adducts for POPs), and enzyme
induction (CYP1A2 and ethoxyreorufin o-
deethylase activity using caffeine breath tests
for POPs). Some biomarkers are already in
use (aminolevulinic acid dehydratase for lead,
β2-microglobuline for cadmium), but most
still need to be validated. The major chal-
lenges to their use are lack of sensitivity and
specificity, and thus more work is needed to
link the health of the marine environment to
that of humans.
Recommendations
Monitoring systems that include the rapid
assessment of contaminants in the ecosystem
and subsequent risk to human populations,
with appropriate internationally distributed
databases, need to be developed and vali-
dated. Such tools would provide early detec-
tion of potential environmental threats and
enhance the ability to prevent human illness.
Because analyses of contaminants are some-
times expensive and time-consuming, we
need to use appropriate markers and indica-
tors, develop new ones, and rigorously vali-
date them all.
Research on oceans and human health
needs to be interdisciplinary and structured
around a “models-based” approach, focusing
on critical themes and attributes of marine
environmental and public health risks. Given
the extent and complex nature of ocean and
human health issues, a program networking
across geographic and disciplinary boundaries
is essential. The overall goal of such a program
would be the early detection of potential
marine-based contaminants, with the ultimate
outcome being the preservation of natural
resources and the prevention of associated
human illness.
Such a program could contain four com-
ponents: a basic mechanistic research compo-
nent, a biomarkers developmental resource
component, an informatics component, and a
training component. Within this context,
research problems would be proposed and
work conducted to find feasible solutions.
Biomarker assessment could be modified,
expanded, and refined to fit specific situations
with dynamic paradigms, and new ocean and
human health interactions could be addressed.
As the research themes are explored, a training
component would be integrated, resulting in
the production of the next generation of ocean
and human health scientists. Informatics
would be continually developed, providing
essential feedback and information to a broad
range of stakeholders, including those of the
international community.
We suggest five initial “models” of human
exposure resulting from ocean/human
interactions: polar regions/native peoples
food-borne risk exposure; marine toxin
aerosols and human health; urban harbors
and exposure; seafood consumption and
health benefits and risks; and tropical coastal
areas and small island states.
This integrative suite of models would
allow a more effective understanding of the
problems presented by the various sources of
anthropogenic and natural contaminants and
their effects on humans by oral, dermal, and
inhalation exposure. They would also allow
an assessment of such critical factors as
chronic versus acute exposures, local versus
distant sources of contaminant risks, and the
degree to which each individual risk is
reversible or irreversible. Further, a models-
based approach to ocean and human health
would allow for an extrapolation of the results
and techniques to different environments.
The success of this suite of models
depends partly on establishing a comprehen-
sive suite of biomarkers, first by identification
and development of new markers, followed
by their validation within an ocean and
human health context. The translation of bio-
markers that are fast, reliable, easy, inexpen-
sive, and internationally available will
enhance the abilities to assess, measure, and
predict both ecosystem stresses and potential
human exposures/health effects.
REFERENCES AND NOTES
Aagaard A, Warman C, Depledge MH, Naylor E. 1995.
Dissociation of heart rate and locomotor activity during
the expression of rhythmic behavior in the shore crab,
Carcinus maenas (L.). Mar Freshw Behav Physiol 26:1–10.
Anantaphruti MT. 2001. Parasitic contaminants in food.
Southeast Asian J Trop Med Public Health 32:S2:212–228.
Anonymous. 1983. Gastrointestinal illness among scuba divers—
New York City. Morb Mortal Wkly Rep 32(44):576–577.
AMAP. 1998. The Arctic Monitoring and Assessment Program:
Arctic Pollution Issues: A State of the Arctic Environment
Report. Oslo, Norway:Arctic Monitoring and Assessment
Program.
Baden DG, Fleming LE, Bean JA. 1995. Marine toxins. In:
Handbook of Clinical Neurology, Vol 21 (FA de Wolff, ed).
Amsterdam:Elsevier Science, 141–175.
Bourdelais AJ, Tomas CR, Naar J, Kubanek J, Baden DG. 2002.
New fish-killing alga in coastal Delaware produces neuro-
toxins. Environ Health Perspect 110:465–470.
Bowen RE, Crumbley C. 1999. Evolving principles in coastal
management: from concept to action. In:Handbook of
Global Environmental Policy and Administration (Soden
DL, Steel BS, eds). New York:Marcel Dekker; 691–714.
Brouwer A, Morse DC, Lans MC, Schurr AG, Murk AJ,
Klasson-Wehler E, et al. 1998. Interactions of persistent
environmental organohalogens with the thyroid hormone
system: mechanisms and possible consequences for ani-
mal and human health. Toxicol Ind Health 14(1–2):59–84.
Clark RB, Frid C, Attrill M. 1997. Marine Pollution. 4th ed.
Oxford, UK:Clarendon Press.
Davidson PW, Myers GJ, Cox C, Axtell C, Shamlaye C, Sloane-
Reeves J, et al. 1998. Effects of prenatal and postnatal
methylmercury exposure from fish consumption on neu-
rodevelopment. JAMA 280(8):701–707.
Deardoff TL, Overstreet RM. 1991. Seafood-transmitted
zoonoses in the United States: the fishes, the dishes, and
the worms. In: Microbiology of Marine Food Products
(Ward DR, Hackney C, eds). New York:Van Nostrand
Reinhold, 211–265.
DeBoer J, Wester PG, Klamer HJC, Lewis WE, Boon JP. 1998.
Do flame retardants threaten ocean life? Nature 394:28–29.
Dewailly É, Ayotte P, Bruneau S, Gingras S, Belle-Isles M, Roy
R. 2000. Susceptibility to infections and immune status in
Inuit infants exposed to organochlorines. Environ Health
Perspect 108(3):205–211.
Dewailly É, Ayotte P, Bruneau S, Lebel G, Levallois P, Weber
JP. 2001. Exposure of the Inuit population of Nunavik (arc-
tic Quebec) to lead and mercury. Arch Environ Health
56(4):350–357.
Dewailly É, Mulvad G, Pedersen HS, Ayotte P, Demers A, Weber
JP, Hansen JC. 1999. Concentration of organochlorines in
human brain, liver, and adipose tissue autopsy samples
from Greenland. Environ Health Perspect 107:823–828.
Ehrhardt M, Knap AH. 1989. A direct comparison of UV fluores-
cence and GC/MS data of lipophilic open-ocean seawater
extracts. Mar Chem 26:176–188.
FAO. 1999. The State of the World Fisheries and Aquaculture
1998. Rome:FAO Fisheries Department.
Fleming LE, Bean JA, Katz D, Hammond R. 2000. The epidemiol-
ogy of seafood poisoning. Seafood and Environmental
Toxins (Hui YH, Kitts D, Stanfield PS, eds). New York:Marcel
Dekker, 287–310.
Fleming LE, Easom J, Baden D, Rowan A, Levin B. 1999.
Emerging harmful algal blooms and human health:
Pfiesteria and related organisms. Toxicol Pathol 27:573–581.
Ford TE. 2000. Response of marine microbial communities to
anthropogenic stress. J Aquat Ecosys Stress Recov
7:75–89.
GAO. 1984. Report to the Hon. Thomas J. Downey, House of
Representatives. Problems in Protecting Consumers from
Illegally Harvested Shellfish (Clams, Mussels, and
Oysters). GAO/HRD-84-36. Washington, DC:General
Accounting Office. 
GESAMP. 2001. Protecting the oceans from land-based activi-
ties. GESAMP Rep Stud 71:41–44.
Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama
K, et al. 1997. Cognitive deficit in 7-year-old children with
prenatal exposure to mercury. Neurotoxicol Teratol
19(6):417–428.
Grattan LM, Oldach D, Perl TM, Lowitt MH, Matuszak DL,
Dickson C, et al. 1998. Learning and memory difficulties
after environmental exposure to waterways containing
toxin-producing Pfiesteria or Pfiesteria-like dinoflagel-
lates. Lancet 352(9127):532–539.
Hackney CR, Pierson MD, eds. 1994. Environmental Indicators
and Shellfish Safety. New York:Chapman and Hill.
Hallegraef GM. 1993. A review of harmful algal blooms and
their apparent global increase. Phycologia 32:79–99.
Harada M. 1995. Minamata disease: methylmercury poisoning
in Japan caused by environmental pollution. Crit Rev
Toxicol 25:1–25.
Harvell CD, Kim K, Burkholder JM, Colwell RR, Epstein PR,
Grimes J, et al. 1999. Diseases in the ocean: emerging
pathogens, climate links and anthropogenic factors.
Science 285:1505–1510.
HEED. 1998. Health, Ecological and Economic Dimensions of
Global Change Program: Emerging Diseases as Indicators
of Change. Health of the Oceans from Labrador to
Venezuela. Year of the Ocean Special Report. NOAA-OGP
and NASA grant NA56GP0623. (Epstein PR, Sherman BH,
Siegfried ES, Langston A, Prasad S, McKay B, eds).
Boston, MA:Center for Health and the Global Environment,
Harvard Medical School.
Heindel JJ, Collman GW, Suk WA. 1998. Endocrine disruptors:
extrapolation from wildlife to human effects. In: Principles
and Processes for Evaluating Endocrine Disruption in
Wildlife (Kendall R, Dickerson R, Giesy J, Suk W, eds).
Pensacola, FL:Society of Environmental Toxicology and
Chemistry Press, 335–347.
Henrickson SE, Wong T, Allen P, Ford T, Epstein PR. 2001.
Marine swimming related illness: implications for monitor-
ing and environmental policy. Environ Health Perspect
109:645–650.
IOC. 2001. The Strategic Plan for the Health of the Ocean Panel
for GOOS. Paris:Intergovernmental Oceanographic
Commission, UNESCO.
Jacobson JL, Jacobson SW. 1996. Intellectual impairment in
children exposed to polychlorinated biphenyl in utero. N
Engl J Med 335(11):783–789.
Kennish MJ. 1997. Practical Handbook of Estuarine and
Marine Pollution. Boca Raton, FL:CRC Press.
Kjellstrom T, Kennedy P, Wallis S, Mantell C. 1986. Physical
and Mental Development of Children with Prenatal
Exposure to Mercury from Fish. Stage 1: Preliminary Test
at Age 4. Stockholm:National Swedish Environmental
Protection Board.
Commentary • Knap et al.
844 VOLUME 110 | NUMBER 9 | September 2002 • Environmental Health Perspectives
Knap AH. 1990. Proceedings of the NATO Advanced Research
Workshop on the Long-Range Atmospheric Transport of
Natural and Contaminant Substances from Continent to
Ocean and Continent to Continent. 10–17 January 1988, St.
George’s, Bermuda. NATO Science Series C:Mathematical
and Physical Sciences, Vol 267. 
———. 2000. Conference Report. NIEHS/UNESCO Meeting on
Indicators of Ocean and Human Health. Mar Pollut Bull
40(5):461–462.
Landrigan PJ, Carlson JE, Bearer CF, Cranmer JS, Bullard R,
Etzel RA, et al.1998. Children’s health and the environment:
a new agenda for prevention research. Environ Health
Perspect 106(suppl 3):787.
Lowe DM, Fossato V, Depledge M. 1995. Contaminant-induced
lysosomal membrane damage in blood cells of mussels
(Mytilus galloprovoncialis) from the Venice Lagoon: an in
vitro study. Mar Ecol Prog Ser 129:189–196.
Marsh DO, Turner MD, Smith JC, Allen P, Richdale N. 1995.
Fetal methyl mercury study in a Peruvian fish-eating popu-
lation. Neurotoxicology 16(4):717–726.
McKeown-Eyssen GE, Ruedy J, Neims A. 1983. Methyl mercury
exposure in northern Quebec. II. Neurologic findings in
children. Am J Epidemio 118(4):470–479.
Mulvad G, Pedersen HS, Hansen JC, Dewailly É, Jul E,
Pedersen MB, et al. 1996. Exposure of Greenlandic Inuit to
organochlorines and heavy metals through the marine
food chain. An international study. Sci Tot Environ
186:137–139.
Myers GJ, Marsh DO, Cox C, Davidson PW, Shamlaye CF,
Tanner MA, et al. 1995. A pilot neurodevelopmental study
of Seychellois children following in utero exposure to
methylmercury from a maternal fish diet. Neurotoxicology
16:629–638.
National Research Council. 1999. From Monsoons to Microbes:
Understanding the Ocean’s Role in Human Health.
Washington DC:National Academy Press.
O’Connor TP, Paul JF. 2000. Misfit between sediment toxicity
and chemistry. Mar Pollut Bull 40(1):59–64.
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P,
Thullen J, et al. 1986. Neonatal effects of transplacental
exposure to PCBs and DDE. J Pediatr 109(2):335–341.
UNESCO. 1996. A Strategic Plan for the Assessment and
Prediction of the Health of the Ocean: A Module of the Global
Ocean Observing System. IOC/INF-1044. Paris:UNESCO. 
———. 2002. The Final Design Plan for the HOTO Module of
GOOS. IOC/INF-1167. Paris:UNESCO. 
Wedderburn J, McFadzen I, Sanger RC, Beesley A, Heath C,
Hornsby M, Lowe D. 2000. The field application of cellular
and physiological biomarkers in the mussel Mytilus edulis,
in conjunction with early life stage bioassays and adult
histopathology. Mar Pollut Bull 40(3):257–267.
WHO. 1946. Preamble to the Constitution of the World Health
Organization. Geneva:World Health Organization.
Commentary • Ocean health, human health, and contamination
Environmental Health Perspectives • VOLUME 110 | NUMBER 9 | September 2002 845
